Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation-Reference-Cited by-同舟云学术

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

Published:2011-12-01 Issue:12 Volume:121 Page:4700-4711
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Chakravarty Debyani,Santos Elmer,Ryder Mabel,Knauf Jeffrey A.,Liao Xiao-Hui,West Brian L.,Bollag Gideon,Kolesnick Richard,Thin Tin Htwe,Rosen Neal,Zanzonico Pat,Larson Steven M.,Refetoff Samuel,Ghossein Ronald,Fagin James A.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference46 articles.

1. Mutations of the BRAF gene in human cancer

2. BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

3. BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer

4. BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study

Cited by 316 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria and potential of mitochondria-targeted therapy in BRAF mutant cancer: A review;Critical Reviews in Oncology/Hematology;2024-11

2. Decision Variables for the Use of Radioactive Iodine in Patients with Thyroid Cancer at Intermediate Risk of Recurrence;Cancers;2024-09-06

3. An update on redifferentiation strategies for radioactive iodine-refractory differentiated thyroid carcinoma;Endocrine;2024-09-04

4. Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine;The Journal of Clinical Endocrinology & Metabolism;2024-08-20

5. Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer;Expert Opinion on Pharmacotherapy;2024-08-12